Combined rosacea treatment protocol using a pulsed dye laser and a dermal bioreparant with trehalose

Chebotareva, Yu.Yu.; Tonakanyan, B.M.; Privalova, E.G.

doi:10.17116/klinderma202322051616

Klin. dermatol. venerol.

2023

DOI: 10.17116/klinderma202322051616

|View full text |Cite

Combined rosacea treatment protocol using a pulsed dye laser and a dermal bioreparant with trehalose

Yu.Yu. Chebotareva,

B.M. Tonakanyan,

E.G. Privalova

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Combination of trehalose and botulinum toxin type A in REVITOX skin treatment protocols

Razumovskaya

2024

Medicinskij sovet

View full text Add to dashboard Cite

This article presents the REVITOX protocol, developed by the author, which includes the combination of REVI products (native hyaluronic acid + trehalose) and botulinum toxin type A (BTA) for the treatment of rosacea and correction of age-related changes. A plethora of studies has demonstrated that trehalose, an exceptional stabilizer of proteins, contributes to maintaining cellular integrity, exhibits antioxidant and angioprotective effects, and has been shown to induce autophagy. In combination with the proven effects of hyaluronic acid and BTA, these properties facilitate the optimal environment for cellular structure functioning, influencing the basic mechanisms of rosacea pathogenesis and mitigating the severity of age-related changes through the balanced elimination of dynamic and static rhytides, stimulation of neocollagenesis and improvement of the mechanical properties of the dermis. By targeting the multifactorial processes of facial aging, improving skin hydration and elasticity, the REVITOX Beauty protocol has ensured the balanced rejuvenation of the perioral and periorbital skin, resulting in a significant improvement in skin quality, as confirmed by the results of 3D diagnostics. After 3 treatment sessions of the REVITOX Derma program, the patients showed a general improvement of facial skin, a visible reduction in erythema and telangiectasia severity, regression of papulopustular elements, enhanced skin hydration and elasticity, and no recurrences at the follow-up. Further studies on the combined use of BTA and REVI will investigate the potential for using these protocols in the treatment of other dermatological conditions, including in combination with energy-based devices and beauty injections.

show abstract

Combination of trehalose and botulinum toxin type A in REVITOX skin treatment protocols

Razumovskaya

2024

Medicinskij sovet

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Combined rosacea treatment protocol using a pulsed dye laser and a dermal bioreparant with trehalose

Cited by 1 publication

References 7 publications

Combination of trehalose and botulinum toxin type A in REVITOX skin treatment protocols

Combination of trehalose and botulinum toxin type A in REVITOX skin treatment protocols

Contact Info

Product

Resources

About